Renal transplantation remains the treatment of choice for end-stage renal disease (ESRD) in regard to patient survival. Iran was one of the first countries in the Middle East that began renal transplantation. In a cross-sectional study, we enrolled all cadaveric renal transplant recipients since 2001 until 2007 in Urmia, Iran. 39 cases had criteria to be included in our study by an aim-based sampling. Data about related variables was collected by checklist. Then collected data were entered in SPSS software ver16 and analyzed by Kaplan-Meier test and descriptive statistics. Mean age of graft recipients was 35.18±14.27. 21 patients (53.8%) were male. They developed ESRD because of DM (7 cases=21.2%), HTN (24.2%), Glomerulopathies (36.4%), Polycystic Disease (PKD) (2.6%), and 5 (15.2%) other causes. 4 recipients (10.3%) were hospitalized again because of ATN after transplant. Acute rejection were seen in 7 (17.9%) of recipients. Surgical complications after transplantation included: Urinoma, lymphocele, and surgical site leakage (each in one case). One year patient survival was 89.7% in this study. 4 recipients died within one to 9 months after transplantation. Death-censored one-year graft survival was 100%. Survival rate of cadaveric transplants is in good range. So according to the possibility of transplanting other organs in this method, it’s recommended to make policies to improve cadaveric transplantation.
Volume : 6
Issue : 4
Pages : 57
Urmia Imam Khomeini Hospital,Urmia University Of Medical Sciences, Urmia, Iran.